🇺🇸 FDA
Patent

US 11578313

CRISPR-Cas effector polypeptides and methods of use thereof

granted A61KA61K31/7088A61K38/00

Quick answer

US patent 11578313 (CRISPR-Cas effector polypeptides and methods of use thereof) held by The Regents of the University of California expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/7088, A61K38/00, A61K38/465, A61K48/00